Life Sciences

Welcome to HS Life Sciences
Display Name
HS Life Sciences
Banner Image
Image

Sarah’s key focus is how do we design and execute better clinical trials, improving access and reducing burden for our patients? Sarah brings 19 years of experience to her role as an Innovation Project Manager in the Translational Medicine group within the Novartis Institutes for BioMedical Research (NIBR). She leads multiple innovative and novel trial technology projects, ranging from digital recruitment of trial subjects to novel data collection methods and looking at ways to better engage with patients during and after study participation.

Complimentary Webinar

The Promise of Next Generation Clinical Trials Register now >

Thursday November 3, 2022 - 9AM PDT / 12PM EDT / 4PM GMT / 5PM CET


With this discussion of ‘Next Generation Clinical Trials”, we continue the series of Translational Medicine webinars. We focus on solutions to the challenge of learning more from clinical trials and meeting patient needs faster.

Professor Anthony O'Hagan is an Emeritus Professor of Statistics at the University of Sheffield, UK.  A major strand of his research has been the elicitation of expert knowledge.  With Professor Jeremy Oakley (University of Sheffield), he developed the Sheffield Elicitation Framework (SHELF), now in version 4.  He has provided consultancy, training, and practical elicitations for several organisations in diverse sectors, including GlaxoSmithKline, Swiss Re and the European Food Safety Authority.

An introductory course for those new to expert elicitation

 

The earlier you can stop development of a therapeutic intervention that will not make it all the way to the clinic the better. Getting that call right is the challenge - but increasing the chances of making the right call is one of the greatest contributions teams can make to reducing costs and increasing profits.